The human gut microbiome is comprised of densely colonizing micro-organisms in dynamic 2 interaction with each other and the host. While the bacterial component of the microbiome is under 3 intense investigation, far less is known about how bacteriophages impact bacterial communities in the 4 gut. We investigated the dynamic effects of phages on a model microbiome using gnotobiotic mice 5 colonized by commensal bacteria that colonize the human infant gut, and found that phage predation 6 not only directly impacts susceptible bacteria but also leads to cascading effects on other bacterial 7 species via inter-bacterial interactions. Using metabolomic profiling, we also found that the shifts in the 8 microbiome caused by phage predation have a direct consequence on the gut metabolome. Our work 9 provides insight into the ecological importance of phages as modulators of bacterial colonization, and 10 additionally suggests the potential impact of gut phages on the host with implications for the use of 11 phages as therapeutic tools to rationally and precisely modulate the microbiome. 12 13 14 15 16 17
Introduction 1
Our bodies contain roughly as many bacterial cells as our own, with the greatest density in the 2 colon at 10 14 cells (Sender et al., 2016) . This microbiome benefits human health via mechanisms 3 including metabolic cross-feeding and immune system priming (Brestoff and Artis, 2013) . Conversely, 4 an imbalanced or depleted microbiome can be deleterious. Diseases associated with an abnormal 5 microbiome include poor nutrient utilization (Smith et al., 2013; Turnbaugh et al., 2006) , gastrointestinal 6 disease (Chang et al., 2008; Frank et al., 2007) , as well as diseases of the liver (Le Roy et al., 2013) , 7 heart (Zhu et al., 2016) , and brain (Hsiao et al., 2013) . As we gain greater understanding of the role of 8 the gut microbiome in human health and disease, the leading question becomes: what factors in the gut 9 influence the microbes that influence us, and how can we leverage this knowledge toward treatments 10 that manipulate the microbiome? 11 Current approaches to modulating the gut microbiome include dietary changes and antibiotics, 12 but these modalities cause broad and potentially long-lasting perturbations. For infants, whose gut 13 microbiomes are in a nascent state, the consequences of perturbations are of particular concern as it 14 can lead to depleted bacterial diversity and instability in the short term (Yassour et al., 2016) and 15 increased incidences of allergic disease (Bisgaard et al., 2011) , overweightness (Ajslev et al., 2011) 16 and asthma (Abrahamsson et al., 2014) in the long term. From both the basic scientific and therapeutic 17 perspectives, strategies are thus needed to more precisely and rationally modulate gut bacteria within a 18 complex community (Schmidt et al., 2018) . A promising approach toward this goal is to study the 19 ecological antagonists of bacteria in the gut, bacteriophages (phages). Analogous to studying natural 20 products or their derivatives for therapeutic purposes (Dias et al., 2012) , studying the role of 21 bacteriophages in the gut may illuminate new approaches for: (1) deliberately and rationally perturbing 22 specific bacteria, (2) elucidating causality as mediated by inter-bacterial and bacterial-host interactions, 23 and (3) ultimately designing precise and predictable approaches to remodel the gut microbiota for 24 therapeutic purposes. 25 Phages are prokaryotic viruses that are among the most abundant microbes in the gut, but also 26 among the least understood (Keen and Dantas, 2018; Mirzaei and Maurice, 2017) . These viruses 27 generally propagate via lytic or lysogenic infection of bacteria, often with species-level specificity. While 28 their metagenomic composition has been associated with diseases such as inflammatory bowel 29 disease (Norman et al., 2015) and malnutrition (Reyes et al., 2015) , little is known about the actual 30 behavior of phages in the gut (Reyes et al., 2013) . Analogous to the importance of understanding apex 31 predators in natural environments (Estes et al., 2011) , elucidating the predation behavior of phages has 32 the potential to provide similar insights in the gastrointestinal ecosystem. However, tracking the cause-33 effect relationship of phage predation on naturally-occurring microbiomes and consequently on host 34 and microbial metabolism is extremely challenging (Fischbach, 2018; Schmidt et al., 2018) . Gnotobiotic 35 4 mice, colonized with a limited and known but still complex collection of bacteria, present an attractive 1 model system for comprehensively characterizing the behavior of phages in the gut environment. 2 In this work, we administered lytic phages to gnotobiotic mice colonized with a defined set of 3 human commensal bacteria and longitudinally-tracked the response of each microbe using high- 4 throughput sequencing and targeted molecular methods. We found that phages cause targeted 5 knockdown of susceptible species in the gut, and further modulate non-targeted bacteria through inter-6 bacterial interactions, resulting in blooms and attrition of previously repressed and promoted species. 7 By comparing the colonization profile of a full bacterial consortia to those omitting phage-targeted 8 species, we delineate the causal effects of simultaneous phage predation. Using broad metabolic 9 profiling, we demonstrate that the compositional shifts in bacteria caused by phage predation also 10 modulate the gut metabolome. These findings have implications for effects on the host, and the 11 potential use of phages for therapeutic purposes. Results 1 Phages are specific for individual species among representative human gut commensals 2 Because the infant gut microbiome is especially vulnerable to perturbations with long-term 3 consequences, we constructed a model microbiota comprised of human facultative-and obligate-4 anaerobic commensal bacterial species known to colonize the infant human gut (Blanton et al., 2016; 5 Gibson et al., 2016; Smith et al., 2013; Subramanian et al., 2014) , and that also can stably co-colonize 6 germ-free mice (Bucci et al., 2016) . The ten selected species represent the major phyla in the human 7 gut microbiome (The Human Microbiome Project Consortium, 2012) Jofre, 1987)), and E. faecalis (VD13 phage (Ackermann et al., 1975) ). 16 We first confirmed the specificity of our phages by testing their ability to lyse a panel of our 17 candidate, and putatively non-susceptible, human gut commensal bacteria. Using a spot assay (Kutter, 18 2009), we tested the susceptibility of each bacteria to 5 µL of each lytic phage (~10 9 pfu/mL). After 19 incubation at 37°C, aerobically or anaerobically depending on bacterial culture conditions, we found 20 that T4, F1, B40-8, and VD13 phages lysed only their susceptible bacteria and had no apparent impact 21 on the other commensal bacteria ( Figure S1 , Table S1 ).
23
Phages knockdown and co-exist with susceptible bacteria in the mammalian gut 24 With little known about the dynamics of phage predation in the mammalian gut, we first aimed to 25 characterize the kinetic behavior of both phages and their targeted bacteria in the context of a larger 26 bacterial community. As shown in Figure 1A , we colonized germfree mice with our defined bacterial 27 consortia of ten species and then introduced phages targeting a subset of these species in the following 28 sequence: T4 and F1 phages targeting E. coli and C. sporogenes, respectively; an equilibration period 29 of two weeks; B40-8 and VD13 phages targeting B. fragilis and E. faecalis, respectively; and a final 30 equilibration period of two weeks. Phages were administered in pairs to probe whether multiple 31 simultaneous perturbations could potentially have synergistic or nullifying effects. Each set contained 32 phage targeting a facultative-and obligate-anaerobe to reduce the potential bias of one phage set over 33 the other. Stool was regularly collected, with greater frequency around perturbations to capture the 34 information-rich dynamical changes (Gerber et al., 2012) , and analyzed for microbial composition using 35 a combination of quantitative PCR and high-throughput sequencing of 16s rRNA amplicons. 36 
6
Our analysis revealed that both phages and their targeted commensal bacteria persist in the 1 gut. After administration, each phage was detectable within ~4-6 h, and continued to be detectable for 2 the duration of the experiment ( Figure 1B ). As non-replicating phage is generally shed completely 3 within the first couple of days (Weiss et al., 2009) , the continued presence of each phage in the gut 4 indicates that the rate of phage production is sufficient to overcome the decay rate from inactivation and 5 intestinal emptying. 6 We further found that phage and bacteria demonstrate a dynamical interaction during the 7 initiation of predation which may provide a window into the in situ properties of phage propagation. The 8 relative number of phage to bacteria (i.e., multiplicity of infection) can determine the kinetics during the 9 early stages of phage infection. The dynamics of B40-8-B. fragilis reveals an initially low fraction of 10 phage per bacteria that peaks and gradually stabilizes to an intermediate level ( Figure 1F ). We see 11 similar results for VD13-E. faecalis ( Figure 1E ), although there is considerable mouse-to-mouse 12 variability in this case. In contrast, the dynamics of T4-E. coli appear to immediately reach steady 13 state within the first sampling ( Figure 1C ). Less is clear for F1-C. sporogenes as a singular peak in the 14 trajectories for four of five mice appears within the first day after phage administration (+0.2d and +1d) 15 ( Figure 1D ). These differential dynamics between each phage-bacteria interaction could be indicative of 16 unique properties of phage propagation or the accessibility of bacteria to infection in their local 17 environments.
19
Phages induce cascading effects in species in the microbiota not directly targeted 20 As shown in Figure 2A , the introduction of phages caused quantitative shifts in bacterial 21 colonization density beyond the target species. After the first set of phage, administered on Day 16.1, A 22 muciniphila blooms to be one of the more abundant species coinciding with a depletion of B. fragilis.
23
The lower-abundance species are also modulated as B. vulgatus, P. mirabilis, and P. distasonis are 24 also enriched after this modulation. Less obvious are the effects due to the second set of phage 25 administered on Day 30.1, even when examining the trajectories of each species separately (Figure 26 S2). By examining the relative changes in bacterial colonization resulting from phage administration as 27 shown in Figure 2B , we found that the knockdown of C. sporogenes and E. coli during the first set of 28 phage administrations results in a rapid and substantial expansion of B. vulgatus, P. mirabilis, and A. Figure S3 ). 33 Despite the modulation of the background flora, phage predation did not induce changes in 34 species richness. As shown compiled in Figure 2A and individually in Figure S2 , none of the bacterial 35 species are completely eliminated after introduction of phage. In fact, the overall bacterial load does not 36 7 change markedly ( Figure S4 ). It has been suggested that the presence of predators can engender 1 greater stability to the ecosystem (Allesina and Tang, 2012) . Calculations of Bray-Curtis similarity in our 2 defined microbiota reveals an increased similarity across mice ( Figure S5A ) and between adjacent time 3 points with each successive introduction of phage ( Figure S5B ). Increased similarity across mice and 4 between time points is indirect evidence of a more stable system that reduces deviations from steady 5 state, suggesting that phage predation may benefit bacterial communities in the gut. Comparing the colonization of mice with and without each phage-targeted species revealed its 10 quantifiable impact on the surrounding microbiota. As conceptually outlined in Figure 3A , comparing 11 bacterial colonization in the presence of Species 1 (full consortia) to its absence (knockout) yields 12 insights into its facilitative and inhibitory roles on the surrounding microbiota. Consequently, attrition of 13 Species 2 colonization in the knockout is indicative of lost promotion from Species 1 and conversely the 14 bloom of Species 3 in the knockout represents lost repression from Species 1. As phage predation 15 equates to bacterial knockdown, its impact will approach that of the knockout ( Figure 3A ). To this end, 16 we quantified the colonization densities of knockout consortia ( Figure 3B ) by inoculating four sets of 17 germfree mice with a bacterial consortia comprising nine species of the original ten-member consortia 18 described earlier, omitting either E. coli, C. sporogenes, B. fragilis, or E. faecalis in turn. As shown in 19 Figure 3C , the colonization profile for each cohort of mice revealed marked compositional differences 20 compared to other dropouts and with the full consortia (corresponding data from Figure 2A ) despite 21 similar overall mean bacterial densities at steady state: full consortia = 1.1 x 10 9 cfu/g stool, E. coli 22 dropout = 6.9 x 10 8 , C. sporogenes dropout = 1.1 x 10 9 , B. fragilis dropout = 9.1 x 10 8 , and E. faecalis 23 dropout = 7.3 x 10 8 . We calculated the influence of each omitted species by comparing the colonization 24 density of each species in its dropout to the full consortia at steady state (Day 16). As shown in Figure   25 3D, each omitted species has a distinct pattern of influence on the defined consortia, which indicates 26 that the knockdown of each species by phage should produce a phenotypically unique result. 27 Using the magnitude of relative changes in colonization with and without phage-targeted 28 species ( Figure 3D ), we hypothesize a bacterial interaction network. To represent the effects of our 29 phage administration, we conflated the effects of the first set of phage (T4 and F1 phages targeting E. fragilis and E. faecalis, respectively), as shown in Figure 4A and 4B, respectively. Because bacterial 32 omission provides the maximal effect possible, the magnitude of inhibitory or facilitative interactions 33 within this interaction network provides an upper-limit to the impact of phage predation, which knocks 34 down but does not eliminate the target bacteria. 35 
8
In some cases, phage-directed knockdown can have a subtractive effect that approaches that of 1 bacterial omission, as exemplified by T4 phage, which substantially reduces the population of E. coli 2 immediately after administration. As indicated by our interaction network ( Figure 4A ), E. coli strongly 3 promotes B. fragilis and strongly represses B. vulgatus through bacterial interactions and thus its 4 knockdown by the first set of phages leads to a contraction in B. fragilis and a bloom of B. vulgatus. The 5 magnitude of these effects approaches the levels observed in the dropout studies ( Figure 4C ), likely 6 due to E. coli being the primary influencer of these species. 7 Causal effects become less clear when two counteracting effects influence a single species, but 8 can still be rationalized using the interaction network. For example, after the administration of our 9 second set of phages that targeted E. faecalis and B. fragilis, we found a relatively minimal impact on 10 the colonization of the surrounding microbiota ( Figure 2C ). However, our interaction network for the 11 second set of phage targeted species ( Figure 4B ) revealed that A. muciniphila, B. ovatus, B. vulgatus, 12 P. distasonis, and P. mirabilis are all repressed by B. fragilis and promoted by E. faecalis. Thus, the 13 simultaneous knockdown of these two phage-targeted species during the second set of phage 14 administered resulted in counteracting losses in repression and promotion, ultimately nullifying their 15 individual effects on the community and leading to a negligible impact on over all bacterial colonization. 16 We also observed interesting temporal dynamic effects on the microbes due to phage-17 predation, which can be explained by bacterial interactions. For example, we observed that P. experiences an initial transient knockdown and its recovery after the first few days coincides with the 25 rescue of its promotion of P. distasonis, thus, explaining a second bloom of P. distasonis beginning 26 after day 3. This effect is similarly observed for P. mirabilis, though to a lesser degree because of the 27 weaker promotion by C. sporogenes. 28 Our results also suggest some deeper cascading effects not captured in our interaction network 29 derived from the dropout experiments. As shown in Figure 4C , knockdown of E. coli and C. sporogenes 30 by the first set of phage leads to an enrichment of A. muciniphila substantially beyond what is described 31 by the dropout experiments. As our study examined the causal effects of four of the ten members of the 32 consortia, it is likely that A. muciniphila experiences additional influence from other members of the 33 microbiota (e.g., B. vulgatus, B. ovatus, P. distasonis, and/or P. mirabilis). Bacterial modulation induced by phages impacts the gut metabolome 1 We sought to characterize the functional effects of phage-predation on the microbiome as 2 reflected in changes in the gut metabolome. Overall, our expectation was that levels of most 3 metabolites would be buffered against fluctuation due to metabolic redundancy across our defined 4 consortia, but compounds associated with microbial pathways unique to particular species in our 5 consortium would be sensitive to perturbations in the bacterial composition. Using untargeted 6 metabolomics, we surveyed the fecal metabolites during various stages of colonization in mice, namely 7 sterile (germfree), after stable bacterial colonization, after introduction of E. coli and C. sporogenes 8 phages, and after introduction of E. faecalis and B. fragilis phages ( Figure 5A ). 9 Overall, phage-directed remodeling of the gut microbiota had a relatively narrow impact on the 10 metabolome. Administration of the first set of phages resulted in statistically significant changes in 17% 11 of examined compounds, with metabolites representing nearly all the KEGG pathways (e.g., amino 12 acids, peptides, carbohydrates, lipids, nucleotides, cofactors/vitamins and xenobiotics) ( Figure 5B and 13 Table S2 ). We also found that the second set of phage had a comparatively limited impact, as only 14 0.7% of metabolites were significantly affected ( Figure 5C and Table S2 ), which coincided with a 15 relatively limited change in the microbiota that was dominated by a decrease in E. faecalis 13 days 16 post-phage ( Figure 5E ). By comparison, introduction of bacteria to germfree mice resulted in broad 17 shifts in the fecal metabolome, enriching 60% and reducing 15% of metabolites across all KEGG 18 pathways ( Figure S6 and Table S2 ). Taken together, these observations suggest that the breadth of 19 metabolomic impact mirrors the extent of compositional shift in the gut microbiota. 20 21 Phages can modulate neurotransmitter metabolites uniquely associated with specific bacteria 22 We observed that in some cases the specificity of phage-predation allows for the targeting of 23 bacterial species and consequently the knockdown of uniquely-associated metabolic products. 24 Tryptamine is a neurotransmitter commonly of plant origin but is also produced via tryptophan 25 decarboxylation by a small number of commensal gut bacteria. While this gene can be found in ~10% 26 of human gut bacterial metagenomes, it has so far been only identified in two genetically-characterized 27 species, R. gnavus and C. sporogenes (Williams et al., 2014) , the latter of which is a member of our 28 defined consortia. BLAST search of tryptophan decarboxylase amino acid sequences from R. gnavus 29 (rumgna_01526) and C. sporogenes (clospo_02083) against the other members of our consortia 30 showed poor protein homology (top hit of 31% identity, Table S3A ), consistent with its unique 31 association to C. sporogenes. During treatment with the first set of phage, we detected a 10-, 17-, and 32 2-fold reduction in tryptamine (0.2, 2, and 13 days, respectively) as shown in the amino acid pathway 33 depicted in Figure 5F . This corresponds with an 840-, 4-, and 4-fold reduction in C. sporogenes, 34 respectively ( Figure 5D ). 35 
10
As another example, the neurotransmitter tyramine is produced via tyrosine decarboxylation by 1 lactic acid bacteria including E. faecalis (Connil et al., 2002) , the sole lactic acid bacteria of our 2 consortia. We found no associations of tyrosine decarboxylase with other consortia members in the 3 literature nor any significant protein homology to the E. faecalis protein (tyrDC) by BLAST (top hit of 4 28% identity, Table S3B ), consistent with tyrosine decarboxylation function solely associated with E. 5 faecalis. Administration of our second set of phage caused a 4-, 2.7-, and 4-fold decrease in tyramine 6 (0.2, 2, and 13 days, respectively) as shown in the amino acid pathway of Figure 5G . This corresponds 7 with a 1.3-, 9-, and 42-fold reduction in E. faecalis, respectively ( Figure 5E ). Due to the limited catalog 8 of experimentally verified microbial metabolites (Dorrestein et al., 2014) , it is difficult to broadly 9 associate specific metabolites to individual species within our consortia. However, the unique 10 associations of tryptamine and tyramine to C. sporogenes and E. faecalis, respectively, suggest clear 11 causal links between phage, bacteria, and metabolite. of the mucin-degrading commensals A. muciniphila and B. vulgatus. 20 We also found significant changes in bile salts due to the first set of phage. Tauro-and glyco-21 conjugated primary bile salts produced by the host undergo microbial transformations including amino 22 acid deconjugation by bile salt hydrolases (BSH) and dehydrogenation by hydroxysteroid 23 dehydrogenases (HSDH). We found that modulation of the gut consortia by the first pair of phages 24 increased the deconjugated bile salt, cholate sulfate, and decreased the conjugated bile salt, 25 taurochenodeoxycholic acid 7-sulfate ( Figure 5F ). This suggests an increased activity of BSH which we 26 found prevalently associated with our consortia (B. fragilis, B. ovatus, B. vulgatus, C. sporogenes, E. 27 faecalis, E. coli, P. distasonis, and P. mirabilis) as described in the MetaCyc database (Caspi et al., 28 2016). We also detected increases in two deconjugated, secondary bile salts that were not detected in 29 germfree mice and thus microbially derived: 12-dehydrocholate and ursocholate. The former is 30 produced by 12a-HSDH activity while the latter is produced by sequential 7a-HDSH and 7b-HDSH Our results demonstrate that lytic phages not only knockdown their bacterial targets, but also 2 affect non-susceptible species within a community of commensal bacteria colonizing the gut through 3 cascading effects. We verified phage-bacteria interactions in vitro and then longitudinally-followed their 4 impact on a defined gut microbiota in a gnotobiotic mouse model. Using knockout experiments in which 5 mice were colonized with all but one member of our defined microbiota, we mapped inter-bacterial 6 interactions and elucidated the causal effects of phage perturbation in our defined microbiota. Our 7 results depict a highly interactive and dynamic community where lytic phage coexist and knockdown 8 targeted bacteria, with an effect that propagates through the other members of the microbiota to 9 ultimately modulate the gut metabolome. molecular biology, a general strategy to confirm the putative role of a gene is to verify loss-of-function 23 using a genetic knockout and then verify gain-of-function by reintroducing the gene to the knockout. 24 Our results suggest that phages can provide similar information for the microbiome, although in a 25 graded rather than absolute manner. For example, sustained knockdown of E. coli using T4 phage 26 results in sustained modulation of the surrounding gut bacteria, effects that approach those observed 27 when E. coli was completely omitted from colonization in the dropout experiments. Similarly, the 28 dynamics of predation by F1 phage, where C. sporogenes is initially knocked down but rapidly recovers 29 within days, provides "knockdown" and "overgrowth" information which we found had a functional effect 30 represented by the delayed bloom in P. distasonis. By extension, the rational deployment of multiple 31 phages could be designed to selectively modulate certain species while minimizing the cascading 32 influence on the surrounding microbiota by leveraging counteracting inter-bacterial interactions, as we 33 observed with the knockdown of E. faecalis and B. fragilis. These results suggest that phages with the 34 appropriate properties could be leveraged as powerful tools to investigate the dynamics and interaction 35 structure of the microbiome, providing either sustained knockdowns or precise transient perturbations. 36 Fascinatingly, our results reveal that phage predation in the gut microbiota has potential impact 1 on the host, as manifested by modulation of the gut metabolome. With microbial metabolites having a 2 substantial role in mediating the interaction between bacteria and the host (Dorrestein et al., 2014) physically inaccessible to phage, has also been proposed to explain why phage-targeted bacteria 23 persist in the gut (Chibani-Chennoufi et al., 2004; Weiss et al., 2009; Zahid et al., 2008) . While 24 additional mechanistic studies would be valuable, the contrast in dynamics between the ratio of B40-25 8-B. fragilis (i.e., an early amplification that peaks and decreases to steady state) and T4-E. coli (i.e., colonized with ten culturable and characterized human commensal strains includes moderate 1 complexity and bacterial diversity while minimizing potentially confounding variables. Our finding that 2 lytic phages can play an unexpectedly broad and substantial role in the gut microbiota is only a glimmer 3 of their potential functional impact as they have a diversity of lifestyles (e.g., temperate), bacterial host 4 ranges, and potential for horizontal gene transfer especially with regards to pathogenicity. By 5 illuminating an important dynamical relationship between phage and commensal bacterial within the 6 gut, we believe our work provides a framework that can guide future investigations of causal 7 mechanisms between the microbiome and disease as well as the identification and development of 8 future therapeutics. placing each mouse into a sterile beaker, collecting the freshly voided feces, and snap-freezing in liquid 33 nitrogen within 30 min. Stool for each mouse was collected at these time points: 0.26, 0.48, 1.08, 1.31, 34 2. 08, 2.31, 3.06, 5.13, 7.06, 8.06, 9.04, 11.04, 13.27, 14.08, 15.08, 16.06, 16.31, 17.06, 17.27, 18.06, 35 15 18.27, 13.08, 21.07, 23.08, 25.08, 27.06, 28.08, 29.08, 30.38, 30.52, 31.08, 31.25, 32.08, 32.31, 33.29, 1 35.10, 37.06, 39.06, 40.15, 42.10, 43.06 days. 2 Dropout experiments were conducted similarly as above with specific differences. Twenty ~8-10 3 week-old, male mice were individually-housed and randomly assigned into four groups with each group 4 in separate sterile isolators. On experimental Day 0, each set of mice were inoculated with 200 µL of a 5 dropout mixture consisting of the defined bacterial consortia without one of the following species: B. 6 fragilis, C. sporogenes, E. faecalis, or E. coli. Stool was collected by the previously described method at 7 these time points: 0. 26, 1.1, 3.1, 7.1, 11.1, and 16.1 (A. muciniphila, C. sporogenes B. fragilis, B. ovatus, B. vulgatus, and P. distasonis) . After incubation, B. 4°C for ~2 h to extract phage and then centrifuging at 4000 rpm at 4°C and sterile filtering the 32 supernatant. Phage titers were measured via plaque assay using the same soft-agar overlay technique. 33 Phage infectivity (i.e., bacterial host range) was determined by a spot titer technique (Kutter, 34 2009) where 5 µL spots of ~10 9 pfu/mL of each phage (or phage buffer as a control) was added to soft-35 16 agar overlays of each bacteria (without phage), prepared as described above. Plates were incubated 1 overnight at 37°C aerobically or anaerobically depending on the bacterial culture conditions. After successful amplification was determined by the presence of a 384 bp band on a 1.5% 17 agarose gel, concentration was measured using a Quan-IT dsDNA high sensitivity assay (Invitrogen). 18 Roughly 120 ng of each amplification product was pooled to generate an aggregated library, from which 19 300-500 bp amplicons were selected using a targeted size selection platform, Pippin Prep with 1.5% 20 agarose cassette (Sage Sciences) according to the manufacturer's instructions. Amplicon size was 21 characterized with an Agilent Technologies 2100 bioanalyzer trace. The aggregated library was 22 denatured with sodium hydroxide and diluted to 7.5 pM in HT buffer (Illumina). 480 µL was then 23 combined with 120 µL of 7.5 pM phiX and loaded onto a MiSeq V2 reagent cartridge (Illumina). 24 Sequencing was conducted with 250 bp paired-end reads using custom sequencing primers: Orbitrap mass analyzer (35,000 mass resolution), as similarly described previously (Am et al., 2014) . 28 Each of four aliquots were analyzed as follows: (1) elution with a C18 column (Waters UPLC BEH C18-29 2.1x100mm, 1.7µm) in positive-ion mode with a water/methanol gradient mobile phase containing 30 0.05% perfluorpentanoic acid (PFPA) and 0.1% formic acid (FA); (2) similarly to the previous method 31 except with a water/acetonitrile/methanol gradient mobile phase containing 0.05% PFPA and 0.01% 32 FA; (3) elution with a separate C18 column in negative-ion mode with a water/methanol gradient mobile 33 phase containing 6.5 mM ammonium bicarbonate, pH 8; (4) elution with a HILIC column (Waters UPLC 34 BEH amide 2.1x150mm, 1.7µm) in negative-ion mode with a water/acetonitritile gradient mobile phase 35 containing 10 mM ammonium formate, pH 10.8. MS analysis utilized dynamic exclusion, alternating 36 18 between MS and data-dependent MS n scans. Scan range covered 70-1000 m/z. Data extraction, peak-1 identification, and quality control was conducted using Metabolon's proprietary software. Compounds 2 were identified and quantified by comparison to a library of standards. 197, 435-438. 5 Chibani-Chennoufi, S., Sidoti, J., Bruttin, A., Kutter, E., Sarker, S., and Brüssow, H. (2004) . In Vitro and 6 In Vivo Bacteriolytic Activities of Escherichia coli Phages: Implications for Phage Therapy. Antimicrobial 7 Agents and Chemotherapy 48, 2558-2569. 8 Connil, N., Le Breton, Y., Dousset, X., Auffray, Y., Rincé, A., and Prévost, H. (2002) . Identification of 9 the <em>Enterococcus faecalis</em> Tyrosine Decarboxylase Operon Involved in Tyramine Gibson, M.K., Wang, B., Ahmadi, S., Burnham, C.-A.D., Tarr, P.I., Warner, B.B., and Dantas, G. (2016) . 
